AP key findings about Mundipharma’s OxyContin sales in China
Associated PressSHANGHAI — The Sackler family’s opioid empire in the United States is collapsing under an avalanche of litigation over marketing tactics. Sales reps at their international affiliate, Mundipharma, have been chasing profits in China using many of the same tactics that Purdue was forced to abandon in the U.S. as the death toll from opioid overdoses soared, interviews and documents obtained by the AP show. — Mundipharma managers required sales reps to copy patients’ private medical records without consent to better target sales, in apparent violation of Chinese law. — Faced with fast-rising sales targets, OxyContin reps in China sometimes disguised themselves as medical staff, putting on white coats and lying about their identity to visit patients in the hospital. — Mundipharma aggressively pushed high doses of opioids in China, despite warnings that higher doses carry higher risks of overdose and death.
History of this topic
China has pain pill addicts too, but no one’s counting them
Associated Press
Fake doctors, pilfered medical records drive Oxy China sales
Associated PressDiscover Related
